MoneyWorks4Me

ABL Bio Technologies informs about quarterly statement on investor complaints

19 Jul 2016 Evaluate

ABL Bio Technologies has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1739.00
Dr. Reddys Labs. 1229.70
Cipla 1318.55
Lupin 1909.20
Zydus Lifesciences 1126.95
View more..